Advancements in SELEX technology which have allowed screening in live cells, called Cell-SELEX, are explored in a thorough Review content published in BioResearch Open up Gain access to, a bimonthly peer-examined open gain access to journal from Mary Ann Liebert, Inc. This article is available free of charge on the BioResearch Open up Gain access to website. An interview with Dr Matt SilverNew era of RNAscope items for RNA-biomarker evaluation in FFPE cells releasedProtein sensor for proprioception found Cell-SELEX uses live cells as targets for binding of molecules known as aptamers, comprised of brief chains of nucleic acids.Dr Goldring adds: ‘Although many experience squeamish about the thought of donating their brains to medical research, it really is vital that people get more samples to conduct research. With an ageing inhabitants increasingly, the incidence of Alzheimer’s and Parkinson’s is likely to increase, making further research a priority.’ Dr Goldring is the supervisor of the Parkinson’s Disease Culture Tissue Bank, started in 2002, and managed by Imperial College London at Charing Cross Medical center, London. The Society supports the Tissue Bank as a major infrastructure resource for users of the Parkinson’s research community who can obtain cells from both Parkinsonian brains and ‘control’ brains for make use of in their research.